Mitochondrial inheritance

In September 6 Nature, Sofia Berlin and Hans Ellegren from Uppsala University, Sweden, examine the controversial clonal inheritance theory for vertebrate mitochondrial DNA (mtDNA) by following co-inheritance of a female-specific nuclear DNA marker (Nature 2001, 413:37-38).They examined the avian W chromosome, most of which is non-recombining and therefore clonally transmitted by females. A polymorphic (CA)n repeat, NVHfp49, on the W chromosome of 53 female peregrine falcons (Falco peregrinus) an

By | September 6, 2001

In September 6 Nature, Sofia Berlin and Hans Ellegren from Uppsala University, Sweden, examine the controversial clonal inheritance theory for vertebrate mitochondrial DNA (mtDNA) by following co-inheritance of a female-specific nuclear DNA marker (Nature 2001, 413:37-38).

They examined the avian W chromosome, most of which is non-recombining and therefore clonally transmitted by females. A polymorphic (CA)n repeat, NVHfp49, on the W chromosome of 53 female peregrine falcons (Falco peregrinus) and 1,625 bp of mtDNA sequence were followed. The patterns of divergence of mtDNA and W-chromosome sequences were completely concordant.

These data support the hypothesis of clonal inheritance of mtDNA from mothers to daughters without recombination.

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS